This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sagara, N. Articles by Katoh, M. Search for Related Content PubMed PubMed Citation Articles by Sagara, N. Articles by Katoh, M.

Mitomycin C Resistance Induced by TCF-3 Overexpression in Gastric Cancer Cell Line MKN28 Is Associated with DT-diaphorase Down-Regulation¹

Genetics and Cell Biology Section, Genetics Division, National Cancer Center Research Institute, Tokyo 104-0045, [N. S., M. K.], and Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo 105-0003 [N. S.], Japan

TCF transcription factors are mediators of the WNT signaling pathway and are antagonized by the transforming growth factor ß signaling pathway. Here human TCF-3 has been cloned and characterized. Differential expression analyses of TCF genes in gastric cancer revealed that TCF-1 was expressed in most cases of primary gastric cancer at almost the same level as in normal gastric mucosa and that TCF-3 was occasionally up-regulated in primary gastric cancer. The TCF-3 expression vector was transfected to gastric cancer cell line MKN28 to establish stable transformants. Three independent MKN28 transformants overexpressing TCF-3 showed about 8-fold resistance to mitomycin C (MMC; IC₅₀, 2.4 µg/ml) compared with MKN28 vector transfectants (IC₅₀ = 0.3 µg/ml). Among the 10 drug resistance-associated genes examined in this study, the DT-diaphorase (DTD) gene was down-regulated in three MKN28 transformants overexpressing TCF-3. DTD mRNA was also down-regulated in primary gastric cancer with TCF-3 up-regulation. In addition, DTD protein was down-regulated in three MKN28 transformants overexpressing TCF-3 compared with MKN28 vector transfectants. DTD is implicated in the activation of MMC in target cells, and DTD down-regulation explains MMC resistance. MMC resistance induced by TCF-3 overexpression is probably due to DTD down-regulation, which might provide a possible target for new therapy of drug-resistant gastric cancer.

This article has been cited by other articles:

				A. Wallqvist, A. A. Rabow, R. H. Shoemaker, E. A. Sausville, and D. G. Covell Establishing Connections between Microarray Expression Data and Chemotherapeutic Cancer Pharmacology Mol. Cancer Ther., March 1, 2002; 1(5): 311 - 320. [Abstract] [Full Text] [PDF]